These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23037168)

  • 1. Possible involvement of hypothalamic nucleobindin-2 in hyperphagic feeding in Tsumura Suzuki obese diabetes mice.
    Miyata S; Yamada N; Kawada T
    Biol Pharm Bull; 2012; 35(10):1784-93. PubMed ID: 23037168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS.
    Foo KS; Brismar H; Broberger C
    Neuroscience; 2008 Oct; 156(3):563-79. PubMed ID: 18761059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat.
    García-Galiano D; Navarro VM; Roa J; Ruiz-Pino F; Sánchez-Garrido MA; Pineda R; Castellano JM; Romero M; Aguilar E; Gaytán F; Diéguez C; Pinilla L; Tena-Sempere M
    J Neurosci; 2010 Jun; 30(23):7783-92. PubMed ID: 20534827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of bone strength and metabolism in type 2 diabetic model Tsumura, Suzuki, Obese Diabetes mice.
    Tanaka H; Yamashita T; Yoneda M; Takagi S; Miura T
    Bone Rep; 2018 Dec; 9():74-83. PubMed ID: 30094297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing hypothalamic nucleobindin 2 levels and decreasing hypothalamic inflammation in obese male mice via diet and exercise alleviate obesity-associated hypogonadism.
    Chen D; Cao S; Chang B; Ma T; Gao H; Tong Y; Li T; Han J; Yi X
    Neuropeptides; 2019 Apr; 74():34-43. PubMed ID: 30503692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
    Nonogaki K; Ohba Y; Sumii M; Oka Y
    Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of cardiovascular function in Tsumura Suzuki obese diabetes, a new model mouse of type 2 diabetes.
    Kawada T; Miyata S; Shimada T; Sanzen Y; Ito M; Hemmi C; Iizuka S; Suzuki W; Mihara K; Aburada M; Nakazawa M
    Biol Pharm Bull; 2010; 33(6):998-1003. PubMed ID: 20522966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleobindin-2/Nesfatin-1 in the Human Hypothalamus Is Reduced in Obese Subjects and Colocalizes with Oxytocin, Vasopressin, Melanin-Concentrating Hormone, and Cocaine- and Amphetamine-Regulated Transcript.
    Psilopanagioti A; Nikou S; Papadaki H
    Neuroendocrinology; 2019; 108(3):190-200. PubMed ID: 30625474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental changes in the hypothalamic mRNA levels of nucleobindin-2 (NUCB2) and their sensitivity to fasting in male and female rats.
    Iwasa T; Matsuzaki T; Tungalagsuvd A; Munkhzaya M; Yiliyasi M; Kuwahara A; Irahara M
    Int J Dev Neurosci; 2016 Apr; 49():46-9. PubMed ID: 26778702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice overexpressing nesfatin/nucleobindin-2 are susceptible to high-fat diet-induced obesity.
    Shimizu H; Tanaka M; Osaki A
    Nutr Diabetes; 2016 Mar; 6(3):e201. PubMed ID: 26950482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraventricular NUCB2/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect.
    Darambazar G; Nakata M; Okada T; Wang L; Li E; Shinozaki A; Motoshima M; Mori M; Yada T
    Biochem Biophys Res Commun; 2015 Jan; 456(4):913-8. PubMed ID: 25534851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone, kisspeptin, and gonadal steroids directly modulate nucleobindin-2/nesfatin-1 in murine hypothalamic gonadotropin-releasing hormone neurons and gonadotropes.
    Hatef A; Unniappan S
    Biol Reprod; 2017 Mar; 96(3):635-651. PubMed ID: 28339602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats.
    Sedbazar U; Maejima Y; Nakata M; Mori M; Yada T
    Biochem Biophys Res Commun; 2013 May; 434(3):434-8. PubMed ID: 23583201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice.
    Horie M; Miura T; Hirakata S; Hosoyama A; Sugino S; Umeno A; Murotomi K; Yoshida Y; Koike T
    Exp Anim; 2017 Oct; 66(4):405-416. PubMed ID: 28701620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NUCB2/nesfatin-1 in the taste buds of rats.
    Cao X; Zhou X; Cao Y; Liu XM; Zhou LH
    Endocr J; 2016; 63(1):37-45. PubMed ID: 26522144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.
    Riva M; Nitert MD; Voss U; Sathanoori R; Lindqvist A; Ling C; Wierup N
    Cell Tissue Res; 2011 Dec; 346(3):393-405. PubMed ID: 22108805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nesfatin-1 as a satiety molecule in the hypothalamus.
    Oh-I S; Shimizu H; Satoh T; Okada S; Adachi S; Inoue K; Eguchi H; Yamamoto M; Imaki T; Hashimoto K; Tsuchiya T; Monden T; Horiguchi K; Yamada M; Mori M
    Nature; 2006 Oct; 443(7112):709-12. PubMed ID: 17036007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of hearing function and histopathologic changes in the cochlea of the type 2 diabetes model Tsumura Suzuki obese diabetes mouse.
    Tsuda J; Sugahara K; Hori T; Kanagawa E; Takaki E; Fujimoto M; Nakai A; Yamashita H
    Acta Otolaryngol; 2016 Nov; 136(11):1097-1106. PubMed ID: 27308832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PPARγ at an Early Stage of Differentiation Enhances Adipocyte Differentiation of MEFs Derived from Type II Diabetic TSOD Mice and Alters Lipid Droplet Morphology.
    Ishibashi K; Takeda Y; Nakatani E; Sugawara K; Imai R; Sekiguchi M; Takahama R; Ohkura N; Atsumi GI
    Biol Pharm Bull; 2017; 40(6):852-859. PubMed ID: 28566629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity.
    Kudo T; Shimada T; Toda T; Igeta S; Suzuki W; Ikarashi N; Ochiai W; Ito K; Aburada M; Sugiyama K
    Xenobiotica; 2009 Dec; 39(12):889-902. PubMed ID: 19925381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.